-
Je něco špatně v tomto záznamu ?
Effects of human plasma proteins on maturation of monocyte-derived dendritic cells
Z Tobiasova-Czetoova, A Palmborg, A Lundqvist, G Karlsson, L Adamson, J Bartunkova, G Masucci, P Pisa
Jazyk angličtina Země Nizozemsko
Typ dokumentu srovnávací studie, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.
Grantová podpora
NI7537
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- buněčná diferenciace účinky léků MeSH
- CD antigeny analýza MeSH
- dendritické buňky * imunologie účinky léků MeSH
- fibrinogen farmakologie MeSH
- imunofenotypizace MeSH
- imunoglobuliny analýza MeSH
- krevní proteiny * farmakologie MeSH
- kultivované buňky MeSH
- lidé MeSH
- melanom krev MeSH
- membránové glykoproteiny analýza MeSH
- monocyty * imunologie účinky léků MeSH
- test smíšené lymfocytární kultury MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
- srovnávací studie MeSH
Dendritic cells (DC) are a promising tool for vaccine therapy due to their unique properties as antigen presenting cells and their ability to prime naive T cells. Increasing evidence suggests that maturation stage of DC critically influences the fate of the immune response. Generation of monocyte-derived DC for clinically applicable immunotherapy requires the use of well-defined components and stringent culture conditions. An alternative strategy is to use human autologous serum. However, its constituents are not stable and reflect the inflammatory condition of the donor. In order to investigate whether DC properties are influenced by proteins present in the plasma, we matured human monocyte-derived DC with four main plasma components: fibrinogen, fibronectin, plasminogen or C-reactive protein. These purified proteins were added at various concentrations on day 6 after the initial differentiation induced by IL-4 and GM-CSF. The maturation was assessed by phenotyping of maturation-associated marker (CD83) and co-stimulatory molecule CD86 as well as IL-12 production. Functional properties of DC were assessed by endocytic activity and mixed leukocyte culture. Our results indicate that fibrinogen had DC-maturation effect comparable to poly-I:C, TNF-alpha and PGE(2) as a positive control, but it failed to induce IL-12 production. The other plasma proteins had no effect on DC maturation. CRP at high concentration had rather inhibitory effect on DC induced lymphocyte function. We conclude that none of the tested plasma components and acute phase proteins sufficiently induce fully competent mature DC. This finding is important for the preparation of human DC-based vaccines supplemented by autologous sera.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13025427
- 003
- CZ-PrNML
- 005
- 20130813142941.0
- 007
- ta
- 008
- 130722s2005 ne d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.imlet.2005.03.009 $2 doi
- 035 __
- $a (PubMed)16154491
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Tobiásová-Czetöová, Z. $7 _AN074001 $u Department of Immunology, 2nd Medical Faculty and Faculty Hospital Motol, Prague, Czech Republic
- 245 10
- $a Effects of human plasma proteins on maturation of monocyte-derived dendritic cells / $c Z Tobiasova-Czetoova, A Palmborg, A Lundqvist, G Karlsson, L Adamson, J Bartunkova, G Masucci, P Pisa
- 504 __
- $a Literatura
- 520 9_
- $a Dendritic cells (DC) are a promising tool for vaccine therapy due to their unique properties as antigen presenting cells and their ability to prime naive T cells. Increasing evidence suggests that maturation stage of DC critically influences the fate of the immune response. Generation of monocyte-derived DC for clinically applicable immunotherapy requires the use of well-defined components and stringent culture conditions. An alternative strategy is to use human autologous serum. However, its constituents are not stable and reflect the inflammatory condition of the donor. In order to investigate whether DC properties are influenced by proteins present in the plasma, we matured human monocyte-derived DC with four main plasma components: fibrinogen, fibronectin, plasminogen or C-reactive protein. These purified proteins were added at various concentrations on day 6 after the initial differentiation induced by IL-4 and GM-CSF. The maturation was assessed by phenotyping of maturation-associated marker (CD83) and co-stimulatory molecule CD86 as well as IL-12 production. Functional properties of DC were assessed by endocytic activity and mixed leukocyte culture. Our results indicate that fibrinogen had DC-maturation effect comparable to poly-I:C, TNF-alpha and PGE(2) as a positive control, but it failed to induce IL-12 production. The other plasma proteins had no effect on DC maturation. CRP at high concentration had rather inhibitory effect on DC induced lymphocyte function. We conclude that none of the tested plasma components and acute phase proteins sufficiently induce fully competent mature DC. This finding is important for the preparation of human DC-based vaccines supplemented by autologous sera.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a CD antigeny $x analýza $7 D015703
- 650 12
- $a krevní proteiny $x farmakologie $7 D001798
- 650 02
- $a buněčná diferenciace $x účinky léků $7 D002454
- 650 02
- $a kultivované buňky $7 D002478
- 650 12
- $a dendritické buňky $x imunologie $x účinky léků $7 D003713
- 650 02
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 02
- $a fibrinogen $x farmakologie $7 D005340
- 650 02
- $a lidé $7 D006801
- 650 02
- $a imunoglobuliny $x analýza $7 D007136
- 650 02
- $a imunofenotypizace $7 D016130
- 650 02
- $a test smíšené lymfocytární kultury $7 D007959
- 650 02
- $a melanom $x krev $7 D008545
- 650 02
- $a membránové glykoproteiny $x analýza $7 D008562
- 650 12
- $a monocyty $x imunologie $x účinky léků $7 D009000
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
- 700 1_
- $a Palmborg, A.
- 700 1_
- $a Lundqvist, A.
- 700 1_
- $a Karlsson, G.
- 700 1_
- $a Adamson, L. $7 gn_A_00001624
- 700 1_
- $a Bartůňková, Jiřina, $d 1958- $7 jn20000400093 $u Department of Immunology, 2nd Medical Faculty and Faculty Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Masucci, G.
- 700 1_
- $a Pisa P
- 773 0_
- $t Immunology Letters $x 0165-2478 $g Roč. 100, č. 2 (2005), s. 113-119 $p Immunol Lett $w MED00002200
- 773 0_
- $p Immunol Lett $g 100(2):113-9, 2005 Sep 15 $x 0165-2478
- 910 __
- $a ABA008 $b B 1588 $y 3 $z 0
- 990 __
- $a 20130722144420 $b ABA008
- 991 __
- $a 20130813143449 $b ABA008
- 999 __
- $a ok $b bmc $g 989240 $s 823827
- BAS __
- $a 3
- BMC __
- $a 2005 $b 100 $c 2 $d 113-119 $i 0165-2478 $m Immunology letters $x MED00002200 $n Immunol Lett
- GRA __
- $a NI7537 $p MZ0
- LZP __
- $a 2013-07/dpbo